{"id":100161816,"date":"2026-09-25T15:08:00","date_gmt":"2026-09-25T12:08:00","guid":{"rendered":"https:\/\/europeanhealtheconomics.com\/?p=100161816"},"modified":"2026-10-08T04:50:12","modified_gmt":"2026-10-08T01:50:12","slug":"rwe-strategy-lead-3","status":"publish","type":"post","link":"https:\/\/europeanhealtheconomics.com\/es\/north-america\/rwe-strategy-lead-3\/","title":{"rendered":"RWE Strategy Lead"},"content":{"rendered":"

Monheim, Germany \/ Brussels, Belgium \/ Slough, UK \/ US.<\/strong><\/p>\n

We are looking for a RWE Strategy Lead Developed Brands, Immunology who is collaborative, solutions-oriented, and passionate about leveraging real world data to improve the patient experience to join our HTA and Payer Team. This role can be based in Europe, either at our headquarters in Brussels, Belgium, or at one of our primary hubs in Monheim, Germany or Slough, United Kingdom. The position is also available in multiple locations across the United States. This hybrid role requires a minimum of 40% on-site presence and 5-10% domestic and international travel.<\/p>\n

You will lead the development and execution of global real-world evidence (RWE) strategies that support the value, safety, effectiveness, and patient impact of UCB\u2019s therapies. You will identify critical evidence needs for existing product lifecycle and translate them into further integrated RWE, epidemiology, outcomes research, and data strategies that inform regulatory, market access, reimbursement, and business decisions, while supporting and expanding our patient access reach. This strategic leadership role requires a deep understanding of evidence generation, healthcare data, and the evolving external landscape. You will drive the use of innovative study designs, registries, real-world data sources, and emerging technologies to address key evidence gaps and ensure decision-makers have the insights needed to improve outcomes for patients. Success in this role requires scientific expertise, strategic thinking, and the ability to influence complex evidence agendas while balancing diverse stakeholder needs and long-term business priorities.<\/p>\n

What you\u2019ll do<\/p>\n

\u2022 Develop and co lead integrated real-world evidence (RWE), epidemiology, outcomes research, and data strategies that support UCB\u2019s assets across the product lifecycle.
\n\u2022 Identify evidence gaps and define research plans that address regulatory, market access, reimbursement, safety, and patient-centered evidence needs.
\n\u2022 Shape evidence-generation strategies using real-world data, registries, external control arms, innovative study designs, and other fit-for-purpose methodologies.
\n\u2022 Anticipate evolving scientific, regulatory, and business challenges and translate them into actionable evidence solutions and investments.
\n\u2022 Oversee the execution of RWE studies and programs, ensuring delivery on time, within budget, and in accordance with quality and governance standards.
\n\u2022 Drive alignment across complex evidence-generation activities, balancing the needs of multiple stakeholders while maximizing impact and efficiency.
\n\u2022 Provide strategic guidance on topics including disease burden, natural history, comparative effectiveness, long-term outcomes, drug utilization, safety commitments, and health technology assessment requirements.
\n\u2022 Leverage emerging technologies, including AI-enabled approaches, to enhance data strategy, evidence generation, and decision-making.
\n\u2022 Mentor and develop RWE talent while contributing to the continued growth of evidence-generation capabilities across the broader organization.
\n\u2022 Represent UCB externally through engagement with scientific experts, research partners, and industry initiatives to advance the use and impact of real-world evidence.<\/p>\n

Interested? For this role we\u2019re looking for the following education, experience and skills Minimum Experience\/Skills Required:<\/p>\n

\u2022 Master’s degree, PhD, MD, or equivalent advanced degree in Epidemiology, Public Health, Health Economics & Outcomes Research (HEOR), Biostatistics, Life Sciences, or a related discipline.
\n\u2022 8+ years of experience within the pharmaceutical, biotechnology, healthcare, or academic sectors with demonstrated involvement in evidence generation, clinical development, market access, regulatory, and\/or payer-related initiatives. Experience with Big Data and AI is an advantage.
\n\u2022 Strong understanding of real-world evidence (RWE), epidemiology, outcomes research, and healthcare data sources.
\n\u2022 Experience developing evidence strategies that support regulatory, reimbursement, clinical, and business decision-making.
\n\u2022 Demonstrated ability to lead complex initiatives and influence stakeholders in a matrix environment.<\/p>\n

Preferred Qualifications<\/p>\n

\u2022 Formal training in epidemiological research methods, outcomes research, health economics, or related quantitative disciplines.
\n\u2022 Experience developing and executing integrated RWE strategies for or with pharmaceutical assets across multiple stages of the product lifecycle.
\n\u2022 Prior leadership experience, including mentoring, coaching, and developing individuals or leading cross-functional teams.
\n\u2022 Expertise supporting health authority, payer, HTA, or market access interactions through evidence generation.
\n\u2022 Experience in Immunology, Dermatology, Respiratory, or other specialty therapeutic areas.
\n\u2022 Familiarity with innovative study designs, registries, external data sources, AI-enabled technologies, and advanced evidence-generation methodologies.<\/p>\n

This job is posted by UCB.<\/p>\n

SOLICITAR EMPLEO<\/a><\/p>\n

This link brings you to the website of UCB.<\/em><\/p>\n

Por favor, mencione que encontr\u00f3 el puesto a trav\u00e9s de EuropeanHealthEconomics.com.<\/strong> \u00a1Gracias y buena suerte!<\/p>\n